Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP after hip microfracture for chondral lesions
NCT02183896Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma in chondral lesion and Femoroacetabular impingement (FAI), sponsored by University of Colorado Denver. Primary endpoint: MRI delayed Gadolinium-Enhanced MRI of Cartilage at 24 months. Planned start Jul 2014; status: withdrawn.
02
Drugs
platelet-rich plasma
03
Conditions
chondral lesionFemoroacetabular impingement (FAI)
Beyond the preview
Go deeper on NCT02183896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183896.